Search results for " development"
Article
Is Not Using a CDMO Slowing Down Your Process Development?
Consider what process development capabilities you have versus what you could possibly gain from working with a CDMO to not only be successful, but also to improve your chances of getting to market …
Article
Developing an Efficient Adenovirus Downstream Purification Process
This application note describes the development of downstream chromatography steps for purification of adenovirus from HEK293 cell culture harvest.
To read the application note click her…
Poster
Biacore™ systems in vaccine development and production
To step up to the challenge, the vaccine industry is adopting new development methods as well as improved and more flexible manufacturing principles to increase production efficiency while assuring va…
Poster
Accurate comparability assessment of a biosimilar interferon in process development
This is exemplified in this study by the use of these systems in the high-throughput process development (HTPD) of a biosimilar molecule, interferon α-2a (IFNα-2a).
Webcast
Accelerate biotech process development
Balancing innovation, speed, and robustness to support biotherapeutic production
Biopharmaceutical process development faces new challenges: shorter time-to-market and changing regulatory expect…
Article
Impurity ELISA automation for faster process development
Host cell proteins (HCPs) produced by cells during biologic manufacturing must be removed from the final product to protect patients. However, it’s challenging to detect HCP, and this step can…
Webcast
Biotech Makers: Solving challenges in process development of a diversifying antibody pipeline
The therapeutic pipeline for antibodies continues to diversify into new modalities including bi-specific, tri-specific, antibody fragments and domain antibodies which bring new challenges to process…
Webcast
Cytiva Seminar Milano: Accelerate Biotech Process Development
Biopharmaceutical process development faces new challenges: shorter time-to-market and changing regulatory expectations for new molecular entities. Implementing tools and solutions are essential for o…
Webcast
Cytiva Seminar Barcelona: Accelerate Biotech Process Development
Biopharmaceutical process development faces new challenges: shorter time-to-market and changing regulatory expectations for new molecular entities. Implementing tools and solutions are essential for o…
Article
How to develop a scalable rAAV process
Adeno-associated virus (AAV) is the most common vector for gene therapy, yet there’s much room to improve production, purification, and analytics. Here we present the latest updates to our wor…